SCHEMBL21891939

SCHEMBL21891939

CC(C)Oc1ccc(-c2ccc(Oc3ccc(S(=O)(=O)c4ccc(C(C)(C)Cl)cc4)cc3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN5 P54829 1/20 0.44
▸ MMP14 P50281 4/20 0.43
▸ MMP2 P08253 3/20 0.43
▸ MMP9 P14780 3/20 0.43
▸ MMP3 P08254 2/20 0.43
▸ MMP1 P03956 3/20 0.42
▸ MMP13 P45452 3/20 0.42
▸ ACACB O00763 1/20 0.42
▸ ACACA Q13085 1/20 0.42
▸ MMP7 P09237 1/20 0.41
▸ MMP8 P22894 1/20 0.41
▸ HTT P42858 2/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ PTGS2 P35354 1/20 0.39
▸ HSD11B1 P28845 1/20 0.38
▸ GCK P35557 3/20 0.37
▸ FFAR4 Q5NUL3 1/20 0.37
▸ NR1H4 Q96RI1 1/20 0.37
▸ ELANE P08246 1/20 0.37
▸ NAMPT P43490 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20007864 0.89 PTPN5 (0.46) PTPN5MMP14MMP2MMP9MMP3
SCHEMBL18407080 0.89 PTPN5 (0.46) PTPN5MMP14MMP2MMP9MMP3
SCHEMBL19382936 0.84 MMP14 (0.48) PTPN5MMP14MMP2MMP9MMP3
SCHEMBL10066694 0.84 MMP14 (0.48) PTPN5MMP14MMP2MMP9MMP3
SCHEMBL22313771 0.84 HTT (0.51) PTPN5MMP14MMP2MMP9MMP3
SCHEMBL19380417 0.81 HTT (0.61) MMP14MMP2MMP9MMP3MMP1
SCHEMBL24795065 0.81 MMP14 (0.45) PTPN5MMP14MMP2MMP9MMP3
SCHEMBL19383057 0.81 MMP14 (0.45) PTPN5MMP14MMP2MMP9MMP3
SCHEMBL19382857 0.80 ACACB (0.52) MMP14MMP2MMP9MMP3MMP1
SCHEMBL25841271 0.80 ACACB (0.52) MMP14MMP2MMP9MMP3MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11111215-B2 Piperidine-based stabilizers and polymers end-capped with the same SOLVAY SPECIALTY POLYMERS USA, LLC (US) 2021-09-07 — — US disclosed
US-20200115340-A1 PIPERIDINE-BASED STABILIZERS AND POLYMERS END-CAPPED WITH THE SAME SOLVAY SPECIALTY POLYMERS USA, LLC (US) 2020-04-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200115340-A1 PIPERIDINE-BASED STABILIZERS AND POLYMERS END-CAPPED WITH THE SAME CAPZA1, UNG, CAPZA2 PTPN5 4706/4885MMP14 2685/4885MMP2 1937/4885
US-11111215-B2 Piperidine-based stabilizers and polymers end-capped with the same CAPZA1, UNG, CAPZA2 PTPN5 4706/4885MMP14 2685/4885MMP2 1937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback